MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Insulin-dependent diabetes mellitus(IODM)"

  • 2023 International Congress

    Сlinical neurological features of diabetic and non-diabetic patients with Parkinson’s disease.

    OK. Kasimova, DT. Akramova (Tashkent, Uzbekistan)

    Objective: In the last decade, attention has been focused on the relationship between neurodegeneration and abnormal insulin signaling in the central nervous system, insulin in…
  • 2023 International Congress

    Diabetic striatopathy presenting without hyperkinetic movements

    S. Bhalja, C. Sarvakar, S. Garg (Ahmedabad, India)

    Objective: To demonstrate a case of Diabetic striatopathy presenting without hyperkinetic movements Background: Diabetic striatopathy is an uncommon neurological complication associated with poorly controlled Diabetes Mellitus…
  • 2022 International Congress

    Acute Hyperglycemia Without Ketosis Related Movement Disorders: A Case Series

    R. Zouari, M. Akkari, C. Jeridi, MZ. Saeid, F. Nabli, S. Blel, S. Ben Sassi (tunis, Tunisia)

    Objective: report 2 patients with different types of movement disorders (MD) revealing an Acute hyperglycemia without ketosis (AHWK). Background: neurological complications of diabetes are multiple,…
  • 2022 International Congress

    A 69-year-old man with seizure-like activity and unresponsiveness

    J. Patino, A. Durand, R. Samudralwar (Houston, USA)

    Objective: Highlight the clinical features and radiologic findings of diabetic striatopathy. Background: Diabetic striatopathy is a rare condition associated with chorea and/or ballism but can…
  • MDS Virtual Congress 2020

    Type 2 diabetes mellitus may worsen severity of motor symptoms in people with Parkinson’s disease

    A. Ben-Joseph, T. Haque, D. Gallagher, C. Budu, R. Chaudhuri, C. Simonet, A. Noyce (London, United Kingdom)

    Objective: We aimed to determine whether co-morbid type 2 diabetes mellitus (T2DM) would impact the motor or non-motor symptom severity in people with Parkinson’s (PwP).…
  • MDS Virtual Congress 2020

    Unraveling the role of amylin oligomers in synucleinopathies

    I. Martinez Valbuena, R. Valenti Azcarate, C. Caballero, I. Marcilla Garcia, I. Amat-Villegas, J. Sanchez, G. Marti-Andres, L. Armengou, M.R Luquin Piudo (Pamplona, Spain)

    Objective: The aim of this work is to elucidate the role of amylin in both alpha-synuclein amyloid formation and Parkinson’s disease (PD) and dementia with…
  • MDS Virtual Congress 2020

    A Fluctuating Qualitative Dermatoglyphic Trait, Dankmeijer’s and Furuhata’s Index as a Risk Marker in Diabetic Parkinson’s Patients of Guyana: A Case-Control Study

    A. Jha, S. D'costa, W. White, M. Chapp, D. Kanhai (Managua, Nicaragua)

    Objective: The current study aims to compare and evaluate the fluctuating qualitative dermatoglyphic trait, Furuhata’s and Dankmeijer’s index as a risk marker in Diabetes and…
  • 2019 International Congress

    Metabolic syndrome and insulin resistance in Parkinson’s disease: could they affect motor or cognitive symptoms?

    M. Hussein, A. Khamis, R. Soliman, S. Ali (Beni Suef, Egypt)

    Objective: The objective of this work was to detect the markers of metabolic syndrome and insulin resistance in patients with PD and to study their…
  • 2018 International Congress

    Role of metformin in diabetic aging female rat brain: a future therapy for neurodegenerative diseases

    P. Kumar, N. Baquer (New Delhi, India)

    Objective: The objective of this study was to investigate effects of metformin on glucose transporter (GLUT1, GLUT3) expression, intracellular calcium levels, expression of synaptic molecules…
  • 2018 International Congress

    The course of Parkinson’s disease in patients with impaired carbohydrate metabolism

    F. Akhmedova, B. Shagazatova, D. Artikova, F. Mirxaydarova (Tashkent, Uzbekistan)

    Objective: To study the state of lipid metabolism in PD patients with concomitant type 2diabetes (with different glucose tolerance and the effect of DA agonist…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley